| Centro Medico Del Carmen, A Medical Corporation | |
|
303 S Juniper St Escondido CA 92025-4924 | |
| (760) 480-9051 | |
| (760) 480-9054 |
| Full Name | Centro Medico Del Carmen, A Medical Corporation |
|---|---|
| Speciality | General Practice |
| Location | 303 S Juniper St, Escondido, California |
| Authorized Official Name and Position | Thomas Lee Watson (CEO) |
| Authorized Official Contact | 7604809051 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Centro Medico Del Carmen, A Medical Corporation 303 S Juniper St Escondido CA 92025-4924 Ph: (760) 480-9051 | Centro Medico Del Carmen, A Medical Corporation 303 S Juniper St Escondido CA 92025-4924 Ph: (760) 480-9051 |
| NPI Number | 1063621738 |
|---|---|
| Provider Enumeration Date | 05/21/2007 |
| Last Update Date | 01/22/2024 |
| Medicare PECOS PAC ID | 7416964580 |
|---|---|
| Medicare Enrollment ID | O20060314000710 |
News Archive
MMP (USA) announces Worldwide Business with kathy ireland exclusive interview with International Cancer Center. Dr. Eduardo Lovo, Executive Director & Chief of the Brain Radiosurgery Unit of ICC, explains, "We make the treatment of many types of cancer affordable and accessible to many patients who have no other recourse for treatment. By using the most effective and efficient technologies and equipment, we're breaking new ground in making advanced cancer treatment affordable."
A new study has been published on the medRxiv* preprint server, which focuses on the development of a dual-antigen COVID-19' T cell' vaccine. This vaccine is developed based on the expression of both S protein and nucleocapsid (N) protein of SARS-CoV-2, using a next-generation human adenovirus serotype 5 (Ad5) platform.
In a new development, health insurer Blue Shield of California has decided not to pay for Roche Holding's drug Avastin to treat breast cancer after health advisers said it was not safe or clinically beneficial. Blue Shield of California with around 3.3 million members, said in a notice posted on its web site that the drug would no longer be covered as a treatment for metastatic breast cancer beginning October 17. It said exceptions may be considered on a case-by-case basis.
Scientists at the Johns Hopkins Kimmel Cancer Center and University of Melbourne report they have used a genetic test that spots bits of cancer-related DNA circulating in the blood to accurately predict the likelihood of the disease's return in some — but not all — of a small group of patients with early-stage colon cancer.
2015 June 4-5 the kick-off meeting of the project HEALTH-TECH is taking place at Kaunas University of Technology (KTU) Santaka Valley. The project is aimed at founding a centre of excellence for healthy ageing.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063621738 | NPI | - | NPPES |
| 00A521930 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | A52193 (California) | Primary |
| Provider Name | Thomas L Watson |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1104865781 PECOS PAC ID: 8022049386 Enrollment ID: I20050825001042 |
News Archive
MMP (USA) announces Worldwide Business with kathy ireland exclusive interview with International Cancer Center. Dr. Eduardo Lovo, Executive Director & Chief of the Brain Radiosurgery Unit of ICC, explains, "We make the treatment of many types of cancer affordable and accessible to many patients who have no other recourse for treatment. By using the most effective and efficient technologies and equipment, we're breaking new ground in making advanced cancer treatment affordable."
A new study has been published on the medRxiv* preprint server, which focuses on the development of a dual-antigen COVID-19' T cell' vaccine. This vaccine is developed based on the expression of both S protein and nucleocapsid (N) protein of SARS-CoV-2, using a next-generation human adenovirus serotype 5 (Ad5) platform.
In a new development, health insurer Blue Shield of California has decided not to pay for Roche Holding's drug Avastin to treat breast cancer after health advisers said it was not safe or clinically beneficial. Blue Shield of California with around 3.3 million members, said in a notice posted on its web site that the drug would no longer be covered as a treatment for metastatic breast cancer beginning October 17. It said exceptions may be considered on a case-by-case basis.
Scientists at the Johns Hopkins Kimmel Cancer Center and University of Melbourne report they have used a genetic test that spots bits of cancer-related DNA circulating in the blood to accurately predict the likelihood of the disease's return in some — but not all — of a small group of patients with early-stage colon cancer.
2015 June 4-5 the kick-off meeting of the project HEALTH-TECH is taking place at Kaunas University of Technology (KTU) Santaka Valley. The project is aimed at founding a centre of excellence for healthy ageing.
› Verified 6 days ago
News Archive
MMP (USA) announces Worldwide Business with kathy ireland exclusive interview with International Cancer Center. Dr. Eduardo Lovo, Executive Director & Chief of the Brain Radiosurgery Unit of ICC, explains, "We make the treatment of many types of cancer affordable and accessible to many patients who have no other recourse for treatment. By using the most effective and efficient technologies and equipment, we're breaking new ground in making advanced cancer treatment affordable."
A new study has been published on the medRxiv* preprint server, which focuses on the development of a dual-antigen COVID-19' T cell' vaccine. This vaccine is developed based on the expression of both S protein and nucleocapsid (N) protein of SARS-CoV-2, using a next-generation human adenovirus serotype 5 (Ad5) platform.
In a new development, health insurer Blue Shield of California has decided not to pay for Roche Holding's drug Avastin to treat breast cancer after health advisers said it was not safe or clinically beneficial. Blue Shield of California with around 3.3 million members, said in a notice posted on its web site that the drug would no longer be covered as a treatment for metastatic breast cancer beginning October 17. It said exceptions may be considered on a case-by-case basis.
Scientists at the Johns Hopkins Kimmel Cancer Center and University of Melbourne report they have used a genetic test that spots bits of cancer-related DNA circulating in the blood to accurately predict the likelihood of the disease's return in some — but not all — of a small group of patients with early-stage colon cancer.
2015 June 4-5 the kick-off meeting of the project HEALTH-TECH is taking place at Kaunas University of Technology (KTU) Santaka Valley. The project is aimed at founding a centre of excellence for healthy ageing.
› Verified 6 days ago
Danicare Family Health, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 701 E Grand Ave Ste 100, Escondido, CA 92025 Phone: 760-294-8898 Fax: 760-294-8827 | |
Dap Health-centro Medico Escondido-1121 Washington Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1121 E Washington Ave, Escondido, CA 92025 Phone: 760-871-0606 Fax: 760-871-3534 | |
Clinica Familia De Santa Maria Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 935 E Pennsylvania Ave, Escondido, CA 92025 Phone: 760-747-7512 | |
Planned Parenthood Of The Pacific Southwest Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 347 W Mission Ave, Escondido, CA 92025 Phone: 760-738-7770 | |
Escondido Family Medicine Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 255 N Ash St Ste 101, Escondido, CA 92027 Phone: 760-745-5832 Fax: 760-745-7847 | |
Valley Immediate Care Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1540 E Valley Pkwy, Escondido, CA 92027 Phone: 760-621-4902 Fax: 760-400-0012 |